■高影响力期刊的病例报告/系列(CR/S)接受率稳步下降,主要是由于引用次数低。这项研究的目的主要是调查CR/S在耳鼻喉科(ORL)领域的文献计量学方面,其次是指导准作者在当前的出版环境中哪种类型的CR/S具有更好的接受和引用机会。
■对2012-2016年ORL科学引文索引(SCI)期刊上发表的CR/S进行了文献计量和引文分析。
■在1月1日之间发表的11种SCIORL期刊的14900种出版物中有1332(8.9%)CR/S,2012年12月31日,2016年。最常见的领域和主题分别是“儿科ORL”(33.2%)和“罕见病例/条件”(47.1%)。“一般ORL”(5.13)和“治疗”(4.93)类别的引用次数最高。只有10%的CR/S有≥10次引用。平均引文计数与期刊影响因子呈正相关(r=0.131,p<0.001),平均作者人数(r=0.151,p<0.001),平均病例数(r=0.192,p<0.001),平均参考数量(r=0.315,p<0.001)和平均WebofScience访问次数(r=0.291,p<0.001)。
■尽管CR/S在ORLSCI期刊中的引用率很低,它们可能在诊断方面服务于重要的主题,治疗,或并发症。这项研究的发现和主要讨论可能会指导在循证医学时代一致发表CR/S的理由。
UNASSIGNED: The rate of
case report/series (CR/S) acceptance by the high impact journals is steadily declining mainly due to low citations. The aim of this study is primarily to investigate the bibliometric aspects of CR/S in the field of otorhinolaryngology (ORL) and secondarily to guide prospective authors as to which type of CR/S have better chances of acceptance and citation in the current publication climate.
UNASSIGNED: Bibliometric and citation analysis of CR/S published in Science Citation Index (SCI) journals of ORL covering the years of 2012-2016 was conducted.
UNASSIGNED: There were 1332 (8.9%) CR/S among 14900 publications in 11 SCI ORL journals published between January 1st, 2012 and December 31st, 2016. The most common published field and subject were the \'pediatric ORL\' (33.2%) and \'rare cases/conditions\' (47.1%) respectively. \'General ORL\' (5.13) and \'treatment\' (4.93) categories had the highest citations. Only 10% of CR/S had ≥10 citations. The mean citation counts were positively correlated with impact factors of journals (r=0.131, p<0.001), mean number of authors (r=0.151, p<0.001), mean number of cases (r=0.192, p<0.001), mean number of references (r=0.315, p<0.001) and mean number of Web of Science visits (r=0.291, p<0.001).
UNASSIGNED: Although CR/S provides low citation rates in ORL SCI journals, they may serve important topics in terms of diagnosis, treatment, or complications. The findings and the main discussions of this study may direct the rationale for the consistent publication of CR/S in the evidence-based medicine era.